Anixa Biosciences Inc (ANIX)

2.57 -0.11 (-4.03%) USD  |  NASDAQ  |  Dec 23, 16:00
2.57 0.00 (0.00%) After-Hours: 20:00
More

Anixa Biosciences Max Drawdown (5Y): 80.00% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for ANIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Halozyme Therapeutics Inc 49.06%
Lexicon Pharmaceuticals Inc 94.56%
Biofrontera Inc --
NexGel Inc --
CEL-SCI Corp 97.97%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -16.27
Beta (5Y) 0.8180
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 67.17%
Historical Sharpe Ratio (5Y) -0.0796
Historical Sortino (5Y) -0.1448
Monthly Value at Risk (VaR) 5% (5Y Lookback) 28.04%